The time-dependent changes in serum immunoglobulin after kidney transplantation and its association with infection.


Journal

Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960

Informations de publication

Date de publication:
2024
Historique:
received: 22 01 2024
accepted: 02 04 2024
medline: 6 5 2024
pubmed: 6 5 2024
entrez: 6 5 2024
Statut: epublish

Résumé

Kidney transplant recipients often experience significant alterations in their immune system, which can lead to increased susceptibility to infections. This study aimed to analyze time-dependent changes in serum immunoglobulin and complement levels and determine the risk factors associated with infection. A retrospective analysis of serum samples from 192 kidney transplant recipients who received transplantations between August 2016 and December 2019 was conducted. The serum samples were obtained at preoperative baseline (T0), postoperative 2 weeks (T1), 3 months (T2), and 1 year (T3). The levels of serum C3, C4, IgG, IgA, and IgM were measured to evaluate immune status over time. The analysis revealed significant decreases in IgG and IgA levels at T1. This period was associated with the highest occurrence of hypogammaglobulinemia (HGG) and hypocomplementemia (HCC), as well as an increased incidence of severe infection requiring hospitalization and graft-related viral infections. Using a time-dependent Cox proportional hazards model adjusted for time-varying confounders, HGG was significantly associated with an increased risk of infection requiring hospitalization (HR, 1.895; 95% CI: 1.871-1.920, P-value<0.001) and graft-related viral infection (HR, 1.152; 95% CI: 1.144-1.160, P-value<0.001). The findings suggest that monitoring serum immunoglobulin levels post-transplant provides valuable insights into the degree of immunosuppression. Hypogammaglobulinemia during the early post-transplant period emerges as a critical risk factor for infection, indicating that serum immunoglobulins could serve as feasible biomarkers for assessing infection risk in kidney transplant recipients.

Identifiants

pubmed: 38707898
doi: 10.3389/fimmu.2024.1374535
pmc: PMC11066164
doi:

Substances chimiques

Immunoglobulins 0
Biomarkers 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1374535

Informations de copyright

Copyright © 2024 Jo, Min, Jo, Han, Ha, Song, Lee and Kim.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.

Auteurs

Eun-Ah Jo (EA)

Department of Surgery, Seoul National University College of Medicine, Seoul, Republic of Korea.
Department of Surgery, Chung-Ang University Hospital, Seoul, Republic of Korea.

Sangil Min (S)

Department of Surgery, Seoul National University College of Medicine, Seoul, Republic of Korea.

Ae Jung Jo (AJ)

Department of Information Statistics, Andong National University, Andong, Republic of Korea.

Ahram Han (A)

Department of Surgery, Seoul National University College of Medicine, Seoul, Republic of Korea.

Jongwon Ha (J)

Department of Surgery, Seoul National University College of Medicine, Seoul, Republic of Korea.

Eun Young Song (EY)

Department of Laboratory Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea.

Hajeong Lee (H)

Department of Nephrology, Seoul National University College of Medicine, Seoul, Republic of Korea.

Yong Chul Kim (YC)

Department of Nephrology, Seoul National University College of Medicine, Seoul, Republic of Korea.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH